Stock listing
BOATS:BIVI BioVie Inc. Stock
US listing (BOATS) of BioVie Inc. · home listing NASDAQ:BIVI
Follow BioVie Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:BIVI
$1.37 USD -0.06 (-4.2%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:BIVI
- Day range
- $1.32 – $1.43 USDNov 2, 2026
- Volume
- 120,482 sharesNov 2, 2026
- Market cap
- $11.90M USDAt the close on Nov 2, 2026 · price × 8.68M shares outstanding
- 52-week range
- $0.82 – $3.79 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $7.14M USDMedian day 296,800 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:BIVI · Home | $1.37 USD | -0.06 (-4.2%) | 120,482 | $1.41 | $1.43 | $1.32 | $1.43 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:BIVI · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.37 | -0.06 | -4.2% | $1.41 | $1.43 | $1.32 | 120,482 | |
| $1.43 | +0.05 | +3.6% | $1.39 | $1.49 | $1.38 | 105,137 | |
| $1.38 | -0.08 | -5.5% | $1.46 | $1.46 | $1.37 | 41,872 | |
| $1.46 | +0.02 | +1.4% | $1.49 | $1.49 | $1.412 | 106,678 | |
| $1.44 | +0.11 | +8.3% | $1.37 | $1.45 | $1.34 | 195,926 | |
| $1.33 | +0.09 | +7.3% | $1.25 | $1.36 | $1.25 | 139,009 | |
| $1.24 | -0.04 | -3.1% | $1.28 | $1.30 | $1.23 | 141,700 | |
| $1.28 | +0.02 | +1.6% | $1.24 | $1.29 | $1.215 | 101,000 | |
| $1.26 | +0.02 | +1.6% | $1.21 | $1.277 | $1.15 | 194,500 | |
| $1.24 | -0.13 | -9.5% | $1.40 | $1.45 | $1.24 | 279,500 | |
| $1.37 | +0.17 | +14.2% | $1.29 | $1.39 | $1.204 | 182,400 | |
| $1.20 | +0.07 | +6.2% | $1.13 | $1.22 | $1.12 | 275,400 | |
| $1.13 | -0.03 | -2.6% | $1.18 | $1.19 | $1.13 | 166,900 | |
| $1.16 | -0.04 | -3.3% | $1.20 | $1.25 | $1.15 | 342,600 | |
| $1.20 | -0.12 | -9.1% | $1.30 | $1.331 | $1.20 | 171,900 | |
| $1.32 | -0.07 | -5.0% | $1.41 | $1.441 | $1.31 | 67,300 | |
| $1.39 | +0.11 | +8.6% | $1.30 | $1.40 | $1.275 | 204,800 | |
| $1.28 | -0.12 | -8.6% | $1.37 | $1.39 | $1.25 | 362,200 | |
| $1.40 | -0.04 | -2.8% | $1.46 | $1.47 | $1.40 | 134,600 | |
| $1.44 | 0.00 | 0.0% | $1.44 | $1.50 | $1.44 | 132,600 | |
| $1.44 | -0.02 | -1.4% | $1.43 | $1.48 | $1.42 | 135,000 | |
| $1.46 | -0.01 | -0.7% | $1.47 | $1.52 | $1.46 | 189,900 | |
| $1.47 | -0.05 | -3.3% | $1.53 | $1.535 | $1.46 | 266,000 | |
| $1.52 | -0.02 | -1.3% | $1.57 | $1.58 | $1.50 | 201,300 | |
| $1.54 | 0.00 | 0.0% | $1.55 | $1.61 | $1.52 | 145,300 | |
| $1.54 | -0.065 | -4.0% | $1.57 | $1.60 | $1.53 | 182,500 | |
| $1.605 | -0.005 | -0.3% | $1.66 | $1.75 | $1.58 | 458,700 | |
| $1.61 | -0.02 | -1.2% | $1.60 | $1.645 | $1.595 | 235,800 | |
| $1.63 | 0.00 | 0.0% | $1.63 | $1.66 | $1.59 | 216,500 | |
| $1.63 | 0.00 | 0.0% | $1.65 | $1.71 | $1.61 | 199,600 | |
| $1.63 | +0.02 | +1.2% | $1.64 | $1.76 | $1.62 | 411,500 | |
| $1.61 | -0.17 | -9.6% | $1.78 | $1.84 | $1.61 | 404,100 | |
| $1.78 | +0.06 | +3.5% | $1.82 | $1.841 | $1.75 | 478,800 | |
| $1.72 | -0.03 | -1.7% | $1.76 | $1.825 | $1.685 | 440,000 | |
| $1.75 | -0.30 | -14.6% | $1.90 | $1.908 | $1.565 | 1,150,800 | |
| $2.05 | +0.12 | +6.2% | $1.90 | $2.12 | $1.88 | 630,100 | |
| $1.93 | +0.02 | +1.0% | $1.92 | $2.02 | $1.91 | 170,500 | |
| $1.91 | -0.06 | -3.0% | $1.95 | $1.99 | $1.89 | 261,700 | |
| $1.97 | -0.10 | -4.8% | $2.04 | $2.12 | $1.90 | 351,100 | |
| $2.07 | +0.07 | +3.5% | $2.055 | $2.20 | $2.00 | 318,700 | |
| $2.00 | -0.03 | -1.5% | $2.04 | $2.08 | $1.96 | 296,800 | |
| $2.03 | 0.00 | 0.0% | $2.02 | $2.12 | $2.005 | 250,200 | |
| $2.03 | -0.21 | -9.4% | $2.25 | $2.27 | $2.00 | 513,200 | |
| $2.24 | -0.04 | -1.8% | $2.30 | $2.45 | $2.18 | 483,000 | |
| $2.28 | +0.12 | +5.6% | $2.374 | $2.49 | $2.28 | 1,551,900 | |
| $2.16 | -0.03 | -1.4% | $2.20 | $2.25 | $2.106 | 483,900 | |
| $2.19 | +0.08 | +3.8% | $2.09 | $2.22 | $2.00 | 763,400 | |
| $2.11 | +0.02 | +1.0% | $2.005 | $2.25 | $1.967 | 922,400 | |
| $2.09 | -0.05 | -2.3% | $2.00 | $2.11 | $1.93 | 1,029,902 | |
| $2.14 | +0.19 | +9.7% | $1.812 | $2.145 | $1.76 | 2,173,771 | |
| $1.95 | +0.09 | +4.8% | $2.155 | $2.48 | $1.80 | 19,763,840 | |
| $1.86 | +0.52 | +38.8% | $1.545 | $2.39 | $1.49 | 49,110,641 | |
| $1.34 | +0.376 | +38.9% | $1.30 | $1.44 | $1.14 | 42,468,762 | |
| $0.964 | -0.206 | -17.6% | $1.13 | $1.14 | $0.945 | 10,538,110 | |
| $1.17 | -0.23 | -16.4% | $1.32 | $1.56 | $1.17 | 2,764,721 | |
| $1.40 | -0.16 | -10.3% | $1.415 | $1.515 | $1.245 | 2,118,574 | |
| $1.56 | 0.00 | 0.0% | $1.65 | $1.70 | $1.48 | 4,877,687 | |
| $1.56 | +0.29 | +22.8% | $1.35 | $3.79 | $1.31 | 126,402,492 | |
| $1.27 | +0.17 | +15.5% | $1.09 | $1.415 | $1.09 | 2,713,517 | |
| $1.10 | +0.101 | +10.1% | $0.99 | $1.155 | $0.985 | 1,249,301 | |
| $0.999 | -0.351 | -26.0% | $1.22 | $1.23 | $0.98 | 3,456,129 | |
| $1.35 | -0.69 | -33.8% | $1.36 | $1.41 | $0.82 | 8,780,978 | |
| $2.04 | +0.21 | +11.5% | $1.89 | $2.09 | $1.87 | 247,942 | |
| $1.83 | +0.21 | +13.0% | $1.63 | $1.90 | $1.535 | 397,681 | |
| $1.62 | +0.10 | +6.6% | $1.50 | $1.65 | $1.46 | 119,436 |
- Ticker
- BOATS:BIVI
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news
BioVie Selected for Late-Breaking Oral Presentation of Bezisterim Long COVID Data at the 4th Long COVID International Conference 2026
Nov 2, 2026
Closed $1.37 (-4.2%) on Nov 2, 2026
BioVie Invited to Present Data on Bezisterim in Long COVID at the NIH’s RECOVER-TLC Third Annual Workshop
Oct 26, 2026
Closed $1.33 (+7.3%) on Oct 26, 2026
BioVie Presents Data on Bezisterim in Parkinson’s Disease at the 2026 American Neurological Association Annual Meeting
Oct 20, 2026
Closed $1.24 (-9.5%) on Oct 20, 2026
BioVie Presents Data on Bezisterim in Long COVID at the 2026 American Neurological Association Annual Meeting
Oct 19, 2026
Closed $1.37 (+14.2%) on Oct 19, 2026
BioVie to Present New Bezisterim Findings in Parkinson’s Disease and Long COVID at the 2026 American Neurological Association Annual Meeting
Oct 14, 2026
Closed $1.16 (-3.3%) on Oct 14, 2026
New to The Street Broadcasts Tonight at 6: 30 PM ET Across the United States, Latin America and MENA, Featuring BioVie, Acurx Pharmaceuticals, Lantern Pharma and SafeSpace Global
Sep 19, 2026
Closed $1.63 (+1.2%) on Sep 21, 2026
Issued by another party
BioVie Announces Topline Results from Phase 2 ADDRESS‑LC Trial Evaluating Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
Sep 15, 2026
Closed $1.75 (-14.6%) on Sep 15, 2026
BioVie to Host Conference Call to Discuss Topline Data from Phase 2 ADDRESS-LC Trial and the Potential of Bezisterim in Long Covid
Sep 14, 2026
Closed $1.75 (-14.6%) on Sep 15, 2026
BioVie Announces Update to Parkinson's Phase 3 Development Program
Sep 9, 2026
Closed $1.97 (-4.8%) on Sep 9, 2026
Decks
Longevity Biotech, Boston, MA (October 2025)
Conference · 22 slides · Oct 23, 2025
2024 World Congress on Parkinson's Disease and Related Disorders
Conference · 13 slides · May 2024
12th Annual Alzheimer's and Parkinson's Drug Development Summit 2024
Conference · 27 slides · April 2024
Investor Presentation (March 2024)
Investor deck · 34 slides · Mar 6, 2024
BioVie Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 23 in the last 12 months · 116 in all · newest Nov 2, 2026 · oldest 2019
- Decks
- 24 decks · latest Oct 23, 2025
Where BioVie Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:BIVI · Home listing | NASDAQ | United States | USD |
| BOATS:BIVI · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about BioVie Inc.